Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis
Authors:
- 1 September 2014
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 274 (1-2) , 20-27
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Technology R&D project (A110330, HI09C1555)
- Ministry of Health & Welfare, Republic of Korea
- Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea
This publication has 30 references indexed in Scilit:
- Gene Therapy of Multiple Sclerosis Using Interferonβ-Secreting Human Bone Marrow Mesenchymal Stem CellsBioMed Research International, 2013
- Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune ResponsePLOS ONE, 2013
- The blood–spinal cord barrier: Morphology and Clinical ImplicationsAnnals of Neurology, 2011
- Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAEJournal of Neuroimmunology, 2010
- Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 miceJournal of Neuroimmunology, 2010
- Chemotactic and Cytotoxic Effects of Minocycline on Human Retinal Pigment Epithelial CellsInvestigative Ophthalmology & Visual Science, 2010
- Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosisGlia, 2008
- Combined treatment with atorvastatin and minocycline suppresses severity of EAEExperimental Neurology, 2008
- Magnetic resonance imaging of blood–spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitisMagnetic Resonance in Medicine, 2007
- Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitisMolecular Immunology, 2007